Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy

Internal Medicine Journal

Volumn 38, Issue 6 B, 2008, Pages 477-495

  Morrissey, C O ^a,b   Bardy, P G ^e   Slavin, M A ^a,c,d   Ananda Rajah, M R ^c   Chen, S C ^f   Kirsa, S W ^d   Ritchie, D S ^c,g   Upton, A ^h  

^a ALFRED HOSPITAL   (Australia)

^b BURNET INSTITUTE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e QUEEN ELIZABETH HOSPITAL   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

^g Cancer and Haematology Division   (Australia)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Empirical; Galactomannan; Haematological malignancy; Polymerase chain reaction; Pre emptive

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CASPOFUNGIN; CYTARABINE; FLUCONAZOLE; FLUDARABINE; GENOMIC DNA; ITRACONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISOLONE; VORICONAZOLE;

ALGORITHM; ASPERGILLUS; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEMATOLOGIC MALIGNANCY; HUMAN; NEUTROPENIA; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RECURRENT FEVER; REVIEW; STEM CELL TRANSPLANTATION; UNSPECIFIED SIDE EFFECT;

ADULT; ALGORITHMS; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLUS; BETA-GLUCANS; EVIDENCE-BASED MEDICINE; FEVER OF UNKNOWN ORIGIN; HUMANS; LEUKEMIA; MANNANS; POLYMERASE CHAIN REACTION; RECURRENCE; STEM CELL TRANSPLANTATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46149085185     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01724.x     Document Type: Review

References (48)

1. Bodey GP. Fungal infection and fever of unknown origin in neutropenic patients. Am J Med 1986 80 : 112 9.
2. Aisner J, Wiernik PH, Schimpff SC. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977 86 : 539 43.
3. Holleran WM, Wilbur JR, DeGregorio MW. Empiric amphotericin B therapy in patients with acute leukemia. Rev Infect Dis 1985 7 : 619 24.
4. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982 72 : 101 11.
5. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989 86 : 668 72.
6. Bennett JE, Powers J, Walsh T, Viscoli C, de Pauw B, Dismukes W et al. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Clin Infect Dis 2003 36 : S117 22.
7. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999 340 : 764 71.
8. Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med 2000 108 : 282 9.
9. Wingard JR, White MH, Anaissie E, Raffalli J, Goodman J, Arrieta A. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group. Clin Infect Dis 2000 31 : 1155 63.
10. Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP et al. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. Ann Intern Med 2001 135 : 412 22.
11. Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 2002 346 : 225 34.
12. Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 2004 351 : 1391 402.
13. de Pauw BE, Sable CA, Walsh TJ, Lupinacci RJ, Bourque MR, Wise BA et al. Impact of alternate definitions of fever resolution on the composite endpoint in clinical trials of empirical antifungal therapy for neutropenic patients with persistent fever: analysis of results from the Caspofungin Empirical Therapy Study. Transpl Infect Dis 2006 8 : 31 7.
14. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995 62 : 341 7.
15. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest 1987 92 : 95 9.
16. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997 15 : 139 47.
17. Hauggaard A, Ellis M, Ekelund L. Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. Acta Radiol 2002 43 : 292 8.
18. Maertens J, Theunissen K, Verhoef G, Verschakelen J, Lagrou K, Verbeken E et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005 41 : 1242 50.
19. Stynen D, Goris A, Sarfati J, Latge JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995 33 : 497 500.
20. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006 42 : 1417 27.
21. Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005 40 : 1762 9.
22. Marr KA, Leisenring W. Design issues in studies evaluating diagnostic tests for aspergillosis. Clin Infect Dis 2005 41 Suppl 6 : S381 6.
23. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Van Lint MT et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004 38 : 913 6.
24. Maertens J, Deeren D, Dierickx D, Theunissen K. Preemptive antifungal therapy: still a way to go. Curr Opin Infect Dis 2006 19 : 551 6.
25. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004 39 : 199 205.
26. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H et al. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995 345 : 17 20.
27. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F et al. Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005 41 : 654 9.
28. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005 5 : 609 22.
29. Einsele H, Hebart H, Roller G, Loffler J, Rothenhofer I, Muller CA et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997 35 : 1353 60.
30. Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mosch C et al. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol 1999 37 : 3865 71.
31. Hebart H, Loffler J, Meisner C, Serey F, Schmidt D, Bohme A et al. Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000 181 : 1713 9.
32. Lass-Florl C, Aigner J, Gunsilius E, Petzer A, Nachbaur D, Gastl G et al. Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol 2001 113 : 180 4.
33. Williamson EC, Leeming JP, Palmer HM, Steward CG, Warnock D, Marks DI et al. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br J Haematol 2000 108 : 132 9.
34. Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 2001 33 : 428 35.
35. Jordanides NE, Allan EK, McLintock LA, Copland M, Devaney M, Stewart K et al. A prospective study of real-time panfungal PCR for the early diagnosis of invasive fungal infection in haemato-oncology patients. Bone Marrow Transpl 2005 35 : 389 95.
36. Halliday C, Hoile R, Sorrell T, James G, Yadav S, Shaw P et al. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Br J Haematol 2006 132 : 478 86.
37. Florent M, Katsahian S, Vekhoff A, Levy V, Rio B, Marie JP et al. Prospective evaluation of a polymerase chain reaction-ELISA targeted to Aspergillus fumigatus and Aspergillus flavus for the early diagnosis of invasive aspergillosis in patients with hematological malignancies. J Infect Dis 2006 193 : 741 7.
38. White PL, Linton CJ, Perry MD, Johnson EM, Barnes RA. The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin Infect Dis 2006 42 : 479 86.
39. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34 : 7 14.
40. Hebart H, Klingspor L, Klingebiehl T, Loeffler J, Tollemar J, Ljungman P et al. PCR-based liposomal amphotericin B treatment following allogeneic stem cell transplantation is a safe treatment strategy: preliminary results from a prospective study. Blood (ASH Annual Meeting Abstracts) 2004 104 : 192.
41. Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhart H, Suarez F, et al. Empirical versus Pre-emptive Antifungal Therapy in High-risk Febrile Neutropenic Patients: A Prospective Randomised Study. 46th American Society of Haematology Annual Scientific Meeting, Orlando, Florida, USA, 2006 Dec 8-12, Abstract 2019.
42. Barnes RA, White L, Bygrave C, Kell J. Impact of Enhanced Diagnosis of Invasive Fungal Infection in High-risk Haematology Patients. 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, 2007 Sept 17-20, Abstract M-569.
43. Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transpl 2000 25 : 867 71.
44. Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis 2007 44 : 402 9.
45. Buchheidt D, Hummel M, Schleiermacher D, Spiess B, Schwerdtfeger R, Cornely OA et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 2004 125 : 196 202.
46. Martino R, Viscoli C. Empirical antifungal therapy in patients with neutropenia and persistent or recurrent fever of unknown origin. Br J Haematol 2006 132 : 138 54.
47. Halkic N, Ksontini R. Images in clinical medicine. Hepatosplenic candidiasis. N Engl J Med 2007 356 : e4.
48. Prentice HG, Kibbler CC, Prentice AG. Towards a targeted, risk-based, anti-fungal strategy in neutropenic patients. Br J Haemotol 2000 110 : 273 84.